Guangdong Transtek Medical Electronics Co., Ltd

SZSE:300562 Stock Report

Market Cap: CN¥3.0b

Guangdong Transtek Medical Electronics Future Growth

Future criteria checks 3/6

Guangdong Transtek Medical Electronics is forecast to grow earnings and revenue by 18.7% and 27.3% per annum respectively. EPS is expected to grow by 18.5% per annum. Return on equity is forecast to be 7.5% in 3 years.

Key information

18.7%

Earnings growth rate

18.5%

EPS growth rate

Medical Equipment earnings growth25.4%
Revenue growth rate27.3%
Future return on equity7.5%
Analyst coverage

Low

Last updated02 Dec 2024

Recent future growth updates

Recent updates

Market Might Still Lack Some Conviction On Guangdong Transtek Medical Electronics Co., Ltd (SZSE:300562) Even After 27% Share Price Boost

Dec 16
Market Might Still Lack Some Conviction On Guangdong Transtek Medical Electronics Co., Ltd (SZSE:300562) Even After 27% Share Price Boost

Guangdong Transtek Medical Electronics (SZSE:300562) Has Some Way To Go To Become A Multi-Bagger

Nov 25
Guangdong Transtek Medical Electronics (SZSE:300562) Has Some Way To Go To Become A Multi-Bagger

Guangdong Transtek Medical Electronics Co., Ltd (SZSE:300562) Stock Rockets 28% But Many Are Still Ignoring The Company

Aug 26
Guangdong Transtek Medical Electronics Co., Ltd (SZSE:300562) Stock Rockets 28% But Many Are Still Ignoring The Company

Estimating The Fair Value Of Guangdong Transtek Medical Electronics Co., Ltd (SZSE:300562)

Apr 23
Estimating The Fair Value Of Guangdong Transtek Medical Electronics Co., Ltd (SZSE:300562)

Guangdong Transtek Medical Electronics' (SZSE:300562) Shareholders May Want To Dig Deeper Than Statutory Profit

Apr 01
Guangdong Transtek Medical Electronics' (SZSE:300562) Shareholders May Want To Dig Deeper Than Statutory Profit

The Market Lifts Guangdong Transtek Medical Electronics Co., Ltd (SZSE:300562) Shares 36% But It Can Do More

Mar 08
The Market Lifts Guangdong Transtek Medical Electronics Co., Ltd (SZSE:300562) Shares 36% But It Can Do More

Earnings and Revenue Growth Forecasts

SZSE:300562 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,93397N/A3091
12/31/20251,53378N/A321
12/31/20241,18761N/A1441
9/30/20241,0337078101N/A
6/30/202499861108124N/A
3/31/2024970605871N/A
12/31/2023884346174N/A
9/30/2023833-26107124N/A
6/30/2023909-316483N/A
3/31/2023967-46527N/A
1/1/20231,065-326485N/A
9/30/20221,385-21117142N/A
6/30/20221,564-55589N/A
3/31/20221,716-3048N/A
1/1/20221,8219-69-1N/A
9/30/20211,76655-208-123N/A
6/30/20211,69065-129-35N/A
3/31/20211,54278-4645N/A
12/31/20201,33770-2178N/A
9/30/20201,1155968155N/A
6/30/202097844-272N/A
3/31/2020887342887N/A
12/31/2019884314375N/A
9/30/201985832-45-13N/A
6/30/201979128-518N/A
3/31/201978823-418N/A
12/31/2018775246085N/A
9/30/2018753385894N/A
6/30/201880441N/A85N/A
3/31/201883811N/A93N/A
12/31/201786718N/A-4N/A
9/30/201785121N/A19N/A
6/30/201780630N/A42N/A
3/31/201778675N/A35N/A
12/31/201677181N/A78N/A
9/30/201676079N/AN/AN/A
3/31/201667455N/A90N/A
12/31/201562950N/A36N/A
9/30/201556238N/AN/AN/A
3/31/201546648N/A27N/A
12/31/201445645N/A54N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300562's forecast earnings growth (18.7% per year) is above the savings rate (2.8%).

Earnings vs Market: 300562's earnings (18.7% per year) are forecast to grow slower than the CN market (25.2% per year).

High Growth Earnings: 300562's earnings are forecast to grow, but not significantly.

Revenue vs Market: 300562's revenue (27.3% per year) is forecast to grow faster than the CN market (13.6% per year).

High Growth Revenue: 300562's revenue (27.3% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 300562's Return on Equity is forecast to be low in 3 years time (7.5%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/03 08:33
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Guangdong Transtek Medical Electronics Co., Ltd is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Chunsheng XieHuatai Research